Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vigdis Nygaard

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 23, 2024
Desmoplastic non-infantile ganglioglioma mimicking diffuse leptomeningeal glioneuronal tumor: precision diagnostics and therapeutic implicationsPitt Niehusmann, Henning Leske, Vigdis Nygaard, et al.
BMC Genomics|March 28, 2003
Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of varianceVigdis Nygaard, Anders Løland, Marit Holden, et al.
NPJ Precision Oncology|June 17, 2026
Towards an ecosystem of clinical decision support tools for precision cancer medicineSigve Nakken, Anders Edsjö, Janne Lehtiö, et al.
Cancer Medicine|October 6, 2021
Novel human melanoma brain metastasis models in athymic nude fox1<sup>nu</sup> mice: Site-specific metastasis patterns reflecting their clinical originHenrik A Svendsen, Torstein R Meling, Vigdis Nygaard, et al.
The Journal of Molecular Diagnostics : JMD|October 28, 2004
Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphomaGunhild Trøen, Vigdis Nygaard, Tor-Kristian Jenssen, et al.
Cancer Research Communications|March 27, 2023
A <i>PRRX1</i> Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver MetastasesVigdis Nygaard, Anne Hansen Ree, Vegar Johansen Dagenborg, et al.
Cancer Letters|June 23, 2015
Metabolic reprogramming supports the invasive phenotype in malignant melanomaIngrid J Bettum, Saurabh S Gorad, Anna Barkovskaya, et al.
BMC Genomics|June 3, 2008
Validation of oligoarrays for quantitative exploration of the transcriptomeVigdis Nygaard, Fang Liu, Marit Holden, et al.
Cancer Immunology Research|February 27, 2019
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number GainAnne Hansen Ree, Vigdis Nygaard, Hege G Russnes, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Acta Oncologica (Stockholm, Sweden)|May 23, 2024
Desmoplastic non-infantile ganglioglioma mimicking diffuse leptomeningeal glioneuronal tumor: precision diagnostics and therapeutic implicationsPitt Niehusmann, Henning Leske, Vigdis Nygaard, et al.
BMC Genomics|March 28, 2003
Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of varianceVigdis Nygaard, Anders Løland, Marit Holden, et al.
NPJ Precision Oncology|June 17, 2026
Towards an ecosystem of clinical decision support tools for precision cancer medicineSigve Nakken, Anders Edsjö, Janne Lehtiö, et al.
Cancer Medicine|October 6, 2021
Novel human melanoma brain metastasis models in athymic nude fox1<sup>nu</sup> mice: Site-specific metastasis patterns reflecting their clinical originHenrik A Svendsen, Torstein R Meling, Vigdis Nygaard, et al.
The Journal of Molecular Diagnostics : JMD|October 28, 2004
Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphomaGunhild Trøen, Vigdis Nygaard, Tor-Kristian Jenssen, et al.
Cancer Research Communications|March 27, 2023
A <i>PRRX1</i> Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver MetastasesVigdis Nygaard, Anne Hansen Ree, Vegar Johansen Dagenborg, et al.
Cancer Letters|June 23, 2015
Metabolic reprogramming supports the invasive phenotype in malignant melanomaIngrid J Bettum, Saurabh S Gorad, Anna Barkovskaya, et al.
BMC Genomics|June 3, 2008
Validation of oligoarrays for quantitative exploration of the transcriptomeVigdis Nygaard, Fang Liu, Marit Holden, et al.
Cancer Immunology Research|February 27, 2019
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number GainAnne Hansen Ree, Vigdis Nygaard, Hege G Russnes, et al.
Oncotarget|November 5, 2017
Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastasesOlga Østrup, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.
Pageof 3